These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8837026)

  • 1. Natural catalytic antibodies.
    Paul S
    Mol Biotechnol; 1996 Jun; 5(3):197-207. PubMed ID: 8837026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate antibody catalysis.
    Gololobov G; Sun M; Paul S
    Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophilic proteolytic antibodies.
    Gololobov G; Tramontano A; Paul S
    Appl Biochem Biotechnol; 2000; 83(1-3):221-31; discussion 231-2, 297-313. PubMed ID: 10826962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic activity of anti-ground state antibodies, antibody subunits, and human autoantibodies.
    Paul S
    Appl Biochem Biotechnol; 1994; 47(2-3):241-53; discussion 253-5. PubMed ID: 7944341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody proteases: induction of catalytic response.
    Gabibov AG; Friboulet A; Thomas D; Demin AV; Ponomarenko NA; Vorobiev II; Pillet D; Paon M; Alexandrova ES; Telegin GB; Reshetnyak AV; Grigorieva OV; Gnuchev NV; Malishkin KA; Genkin DD
    Biochemistry (Mosc); 2002 Oct; 67(10):1168-79. PubMed ID: 12460115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to sequence-specific antibody proteases. The use of haptens mimicking both a transition state and a distorted ground state.
    Smith RM; Yuan P; Weiner DP; Dutton CR; Hansen DE
    Appl Biochem Biotechnol; 1994; 47(2-3):329-42; discussion 342-3. PubMed ID: 7944347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiotypic mimicry of a catalytic antibody active site.
    Johnson G; Moore SW
    Mol Immunol; 2002 Oct; 39(5-6):273-88. PubMed ID: 12220886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural catalytic immunity is not restricted to autoantigenic substrates: identification of a human immunodeficiency virus gp 120-cleaving antibody light chain.
    Paul S; Kalaga RS; Gololobov G; Brenneman D
    Appl Biochem Biotechnol; 2000; 83(1-3):71-82; discussion 82-4, 145-53. PubMed ID: 10826950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elicitation of carboxylesterase activity in antibodies by reactive immunization with labile organophosphorus antigens: a role for flexibility.
    Schowen RL
    J Immunol Methods; 2002 Nov; 269(1-2):59-65. PubMed ID: 12379352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a catalytic antibody with a serine protease active site.
    Zhou GW; Guo J; Huang W; Fletterick RJ; Scanlan TS
    Science; 1994 Aug; 265(5175):1059-64. PubMed ID: 8066444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-directed mutagenesis of proteolytic antibody light chain.
    Gao QS; Sun M; Rees AR; Paul S
    J Mol Biol; 1995 Nov; 253(5):658-64. PubMed ID: 7473741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies.
    Mitsuda Y; Planque S; Hara M; Kyle R; Taguchi H; Nishiyama Y; Paul S
    Mol Biotechnol; 2007 Jun; 36(2):113-22. PubMed ID: 17914190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
    Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I
    J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-Mediated Catalysis in Infection and Immunity.
    Bowen A; Wear M; Casadevall A
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28674034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic activity of certain antibodies as a potential tool for drug synthesis and for directed prodrug therapies.
    Wójcik T; Kieć-Kononowicz K
    Curr Med Chem; 2008; 15(16):1606-15. PubMed ID: 18673227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism and functional role of antibody catalysis.
    Paul S
    Appl Biochem Biotechnol; 1998 Oct; 75(1):13-24. PubMed ID: 10214694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and multiple hydrolytic sites in epitopes recognized by catalytic anti-peptide antibodies.
    Paul S; Johnson DR; Massey R
    Ciba Found Symp; 1991; 159():156-67; discussion 167-73. PubMed ID: 1720373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune recognition, antigen design, and catalytic antibody production.
    Tramontano A
    Appl Biochem Biotechnol; 1994; 47(2-3):257-73; discussion 273-5. PubMed ID: 7944342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Completing the circle.
    Schultz PG; Lerner RA
    Nature; 2002 Aug; 418(6897):485. PubMed ID: 12152057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.